Marker Therapeutics, Inc. Uncategorized Contracts & Agreements
16 Contracts & Agreements
- Work Order #1 between Marker Therapeutics, Inc. and Cell Ready LLC dated February 22, 2024 (Filed With SEC on March 26, 2024)
- Description of Securities of Marker Therapeutics, Inc (Filed With SEC on March 26, 2024)
- Sponsored Research Contract between Baylor College of Medicine and Marker Therapeutics, Inc. dated November 16, 2018 (Filed With SEC on March 15, 2019)
- Board Observer and Director Nomination Agreement with New Enterprise Associates, Inc (Filed With SEC on October 17, 2018)
- FIRST AMENDMENT (Filed With SEC on June 26, 2017)
- CONFIDENTIAL TREATMENT REQUESTED BY TAPIMMUNE, INC. (Filed With SEC on August 15, 2016)
- AMENDMENT TO (Filed With SEC on November 16, 2015)
- AMENDMENT TO (Filed With SEC on November 16, 2015)
- AMENDED AND RESTATED RESTRUCTURING AGREEMENT (Filed With SEC on June 5, 2015)
- RESTRUCTURING AGREEMENT (Filed With SEC on June 3, 2015)
- [SIGNATURE PAGE TO EA AMENDMENT FOLLOWS] (Filed With SEC on March 10, 2015)
- OLYMPUS SECURITIES, LLC (Filed With SEC on January 12, 2015)
- OPTION AGREEMENT (Filed With SEC on April 15, 2014)
- TECHNOLOGY OPTION AGREEMENT (Filed With SEC on June 4, 2010)
- __________ (Filed With SEC on April 10, 2009)
- __________ (Filed With SEC on April 10, 2009)
